Expertise in
7
conditions

Kevin C. Talbot

Oxford, ENG, GB 
Expertise in
7
conditions
Oxford, ENG, GB 

Overview

Kevin Talbot practices practicing medicine in Oxford, United Kingdom.

Mr. Talbot is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Frontotemporal Dementia, Spinal Muscular Atrophy (SMA), and Gastrostomy.

He is actively involved in clinical research, co-authoring 221 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Warwickshire, United Kingdom
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
Enrollment Status: Terminated
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: WVE-004
Study Phase: Phase 1/Phase 2

221 Total Publications

Erratum to "Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids" [Pharmacological Reviews 78 (2026) 100113].
Erratum to "Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids" [Pharmacological Reviews 78 (2026) 100113].
Journal: Pharmacological reviews
Published: May 20, 2026

Frequently Asked Questions about Kevin C. Talbot

Is Kevin C. Talbot a top-rated expert for Primary Lateral Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Kevin C. Talbot is classified as an Elite expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kevin C. Talbot participate in research or clinical trials?

Yes. Kevin C. Talbot has published 221 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Kevin C. Talbot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Talbot's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile